Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
eXoZymes
AddedFeb 17, 2024
UpdatedJul 5, 2026
eXoZymes

eXoZymes

Series A

Invizyne, a US-based company, designs enzymes and constructs cell-free enzymatic pathways for scalable biomanufacturing.

HQ
Monrovia, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Invizyne, founded in Monrovia, USA, focuses on revolutionizing biomanufacturing through innovative enzyme design and cell-free enzymatic pathways. Their core mission is to create sustainable and efficient manufacturing processes for fuels, foods, medicines, and chemical products. By avoiding the limitations of cell-based or immobilized biomanufacturing technologies, Invizyne aims to offer scalable solutions that operate continuously and unassisted outside of living cells.

Notable affiliated individuals include experts in enzyme biology and biomanufacturing, though specific names are not provided. Invizyne has achieved significant milestones in developing a cell-free technology platform that combines the scalability of chemistry with the power of enzyme biology. This innovation has positioned them as a key player in next-generation biomanufacturing, impacting various markets by providing more sustainable and efficient production methods.

eXoZymes - Similar Companies

Cell-Free Bioinnovations logo

Cell-Free Bioinnovations

cfb9.com

Enzymatics logo

Enzymatics

Infinite Enzymes logo

Infinite Enzymes

Elemental Enzymes logo

Elemental Enzymes

Cascade Biocatalysts logo

Cascade Biocatalysts

EnzymeBioSystems logo

EnzymeBioSystems

Evozym Biologics logo

Evozym Biologics

Zymtronix logo

Zymtronix

zymtronix.com

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Cellibre logo

Cellibre

cellibre.com

Zymochem logo

Zymochem

zymochem.com

Novozymes logo

Novozymes

novozymes.com

Aether Bio logo

Aether Bio

aetherbio.com

Antheia logo

Antheia

antheia.bio

Synlife logo

Synlife

synlifebio.com

eXoZymes - Quick Facts

Who are eXoZymes' competitors?

Companies similar to eXoZymes include Cell-Free Bioinnovations, Enzymatics, Infinite Enzymes and Elemental Enzymes.

When was eXoZymes founded?

eXoZymes was founded in 2014.

Where is eXoZymes' headquarters located?

eXoZymes' headquarters is located in Monrovia, CA, US.

When was eXoZymes' last funding round?

eXoZymes' most recent funding round was for $3.8M (USD) in October 2023.

How much has eXoZymes raised to-date?

As of Oct 11, 2023, eXoZymes has raised a total of $3.8M (USD).

How many employees does eXoZymes have?

eXoZymes has 16 employees as of Feb 4, 2024.

eXoZymes - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biomanufacturing
  • Enzyme Design
Unique IDs
  • secCik: 0002010788
  • ticker: EXOZ